RESCRIPTOR - 49702-225-17 - (delavirdine mesylate)

Alphabetical Index


Drug Information of RESCRIPTOR

Product NDC: 49702-225
Proprietary Name: RESCRIPTOR
Non Proprietary Name: delavirdine mesylate
Active Ingredient(s): 200    mg/1 & nbsp;   delavirdine mesylate
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of RESCRIPTOR

Product NDC: 49702-225
Labeler Name: ViiV Healthcare Company
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020705
Marketing Category: NDA
Start Marketing Date: 20120411

Package Information of RESCRIPTOR

Package NDC: 49702-225-17
Package Description: 180 TABLET in 1 BOTTLE (49702-225-17)

NDC Information of RESCRIPTOR

NDC Code 49702-225-17
Proprietary Name RESCRIPTOR
Package Description 180 TABLET in 1 BOTTLE (49702-225-17)
Product NDC 49702-225
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name delavirdine mesylate
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20120411
Marketing Category Name NDA
Labeler Name ViiV Healthcare Company
Substance Name DELAVIRDINE MESYLATE
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of RESCRIPTOR


General Information